Title of article :
Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies
Author/Authors :
Noorbakhsh, Mohammad-Foad Division of Pharmacology and Toxicology - Department of Basic Sciences - School of Veterinary Medicine - Shiraz University , Shaterzadeh- Yazdi, Hanieh Research Center of Pardis Hospital, Mashhad , Hayati, Farzad Research Center of Pardis Hospital, Mashhad , Samarghandian, Saeed Noncommunicable Disease Research Center - Neyshabur University of Medical Sciences, Neyshabur - Department of Basic Medical Sciences - Neyshabur University of Medical Sciences , Farkhondeh, Tahereh Cardiovascular Diseases Research Center - Birjand University of Medical Sciences
Abstract :
Lung as vital organ is exposed to many injurious agents that can cause
inflammation and oxidative stress, which are potential causes in the
pathogenesis of lung diseases. Nigella sativa, usually introduced as black seed,
has been considered for treatment of various diseases and is one the most
widely investigated herbs. Thymoquinone (TQ) is the major component of the
volatile oil of black seed (54%) which has been indicated to anti-oxidant, antiinflammatory and anti-neoplastic properties. There is interesting to study on
TQ effect as a therapeutic agent for various diseases in both in vivo and in vitro
conditions. In this comprehensive review, we summarized the recent studies
related to the effectiveness of TQ on lung disorders such as inflammatory lung
diseases, lung fibrosis, asthma and lung cancer. It is concluded that TQ with
anti-inflammatory, anti- oxidant, anti-asthmatic and anti- tumor activity can
provide therapeutic effects against lung disorders. However, more investigation
is needed to produce TQ as a pharmaceutical preparation for human studies.
Keywords :
Thymoquinone , Lung inflammation , Asthma , Lung fibrosis , Lung cancer
Journal title :
Tanaffos (Respiration)